Beslutningen om, hvorvidt amning skal fortsættes/ afbrydes, eller om behandling med Doribax skal fortsættes/ afbrydes, bør foretages under hensyntagen til amningens fordel for barnet og Doribax- behandlingens fordel for kvinden.
A decision on whether to continue/discontinue breast-feeding or to continue/discontinue therapy with Doribax should be made taking into account the benefit of breast-feeding to the child and the benefit of Doribax therapy to the woman.